1 Matching Annotations
  1. Aug 2016
  2. clinicaltrials.gov clinicaltrials.gov
    Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC). - Full Text View - ClinicalTrials.gov
    1
    1. kerfors 10 Aug 2016
      D419AC00001

      D-code

      DCODE
    Visit annotations in context

    Tags

    Annotators

    URL

    clinicaltrials.gov/ct2/show/NCT02453282